Tag Archives: Expert

Real estate investing news and tips with Kathy Fettke, best selling author of Retire Rich with Rentals, Co-CEO of Real Wealth Network and Host of the Real Wealth Show and regular guest expert on FOX News, CNN, and CNBC – Real Wealth Show | Real Estate Investing | Turnkey Rental Property | Cash Flow | Notes | Private Lending | Flipping | Wholesa


Real estate investing news and tips with Kathy Fettke, best selling author of Retire Rich with Rentals, Co-CEO of Real Wealth Network and Host of the Real Wealth Show and regular guest expert on FOX News, CNN, and CNBC – Real Wealth Show | Real Estate Investing | Turnkey Rental Property | Cash Flow | Notes | Private Lending | Flipping | Wholesa

from Real Wealth Show | Real Estate Investing | Turnkey Rental Property | Cash Flow | Notes | Private Lending | Flipping | Wholesa

Price: USD 0
View Details about Real estate investing news and tips with Kathy Fettke, best selling author of Retire Rich with Rentals, Co-CEO of Real Wealth Network and Host of the Real Wealth Show and regular guest expert on FOX News, CNN, and CNBC

Kevin Bupp | Real Estate Investing |Commercial Real Estate|Entrepreneur | Cash Flow Investor | Landlord | Passive Income | Mobile Home Park Operator | Multifamily Apartment Investing | Finance Expert | Syndication | Flipping | Wholesaling | Turnkey Renta – Real Estate Investing For Cash Flow Hosted by Kevin Bupp. The #1 Commercial Real Estate Investing Teaching You How To Create We


a href=”https://itunes.apple.com/us/podcast/real-estate-investing-for-cash-flow-hosted-by-kevin/id791316884?mt=2&uo=4″ rel=”nofollow”>
Kevin Bupp | Real Estate Investing |Commercial Real Estate|Entrepreneur | Cash Flow Investor | Landlord | Passive Income | Mobile Home Park Operator | Multifamily Apartment Investing | Finance Expert | Syndication | Flipping | Wholesaling | Turnkey Renta – Real Estate Investing For Cash Flow Hosted by Kevin Bupp. The #1 Commercial Real Estate Investing Teaching You How To Create We

from Real Estate Investing For Cash Flow Hosted by Kevin Bupp. The #1 Commercial Real Estate Investing Teaching You How To Create We

Price: USD 0
View Details about Kevin Bupp | Real Estate Investing |Commercial Real Estate|Entrepreneur | Cash Flow Investor | Landlord | Passive Income | Mobile Home Park Operator | Multifamily Apartment Investing | Finance Expert | Syndication | Flipping | Wholesaling | Turnkey Renta

Adsense Expert

Adsense Expert
Adsense Expert
How To Get Started With Google Adsense & Make Huge Cash Profits In No Time At All & With Very Little Effort. Get 355 Free Adsense Websites And 43 Adsense E-books, Softwares And Videos Valued At Over ,900.00
Adsense ExpertAdsense ExpertHOW+TO+VIDEOShttp://villamor77.ckbks.hop.clickbank.netAdsense ExpertHow To Get Started With Google Adsense & Make Huge Cash Profits In No Time At All & With Very Little Effort. Get 355 Free Adsense Websites And 43 Adsense E-books, Softwares And Videos Valued At Over ,900.00Adsense Experthttp://www.share-a-ton.com/wp-content/uploads/2015/10/ckbks.jpgготовим

Ellen Feigal, MD, Former Senior Executive with CIRM and the National Cancer Institute (NCI), Joins NDA Partners as Premier Expert


(PRWEB) January 09, 2015

Dr. Carl Peck, MD, Chairman of NDA Partners LLC announced today that Ellen G. Feigal, MD, has joined the firm as a Premier Expert consultant. NDA Partners Premier Experts are top tier consultants whose expertise and professional stature enable them to bring extraordinary value to the company’s clients. Premier Experts collaborate to design and implement critical solutions to help clients successfully develop their medical products, pursue optimal regulatory pathways, build companies that are attractive to professional investors, and initiate access to global markets.

Dr. Feigal was formerly Senior Vice President of Research and Development at the California Institute for Regenerative Medicine; Executive Medical Director, Global Development, at Amgen; and Chief Medical Officer at Insys Therapeutics. She was a founding Director of the American Course on Drug Development and Regulatory Sciences. The course was developed under her leadership as a collaborative effort with the FDA, UC San Francisco’s Department of Bioengineering and Therapeutic Sciences, its Center for Drug Development Sciences, and the European Center of Pharmaceutical Medicine at the University of Basel. She has worked in clinical research and product development in positions at the Federal Government and non-profit institutes including Director of Medical Devices and Imaging at the Critical Path Institute, and Vice President of Clinical Sciences and Deputy Scientific Director at the Translational Genomics Research Institute. Dr. Feigal directed the National Cancer Institute’s (NCI) Division of Cancer Treatment and Diagnosis after serving as Deputy Director, and was a senior investigator in the Cancer Therapy Evaluation Program.

“Dr. Feigal is at the forefront of medical research and drug development in a broad spectrum of diseases, and brings industry-leading expertise for products under development to treat cancer, hematologic and neurologic disorders,” said Dr. Peck. “These are areas where many promising new therapies are entering the drug development pipelines of our clients, and Dr. Feigal will be a welcome and invaluable contributor to their success.”

Dr. Feigal earned an MD at UC Davis, completed an internal medicine residency at Stanford, and a hematology/oncology fellowship at UC San Francisco. She was on the faculty at UC San Francisco, and UC San Diego, before joining the NCI.

About NDA Partners

NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 40 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.








NDA Partners announced today that Ellen G. Feigal, MD, an internationally recognized expert in therapeutic product development, hematology-oncology, cell therapies, and regulatory science, has joined the firm as a Premier Expert consultant. Dr. Feigal previously served as the Senior Vice President of Research and Development at the California Institute for Regenerative Medicine, and directed the Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI). Ellen Feigal, MD, Former Senior Executive with CIRM and the National Cancer Institute (NCI), Joins NDA Partners as Premier Expert отзывы topodin

Former GlaxoSmithKline Senior Executive Agnes Westelinck Joins NDA Partners as a Premier Expert Consultant


Madison, Virginia (PRWEB) August 16, 2014

Dr. Carl Peck, MD, Chairman of NDA Partners LLC announced today that Agnes Westelinck, PharmD, has joined the firm as a Premier Expert consultant. NDA Partners Premier Experts are top tier consultants whose expertise and professional stature enable them to bring extraordinary value to the company’s clients. Premier Experts collaborate to design and implement critical solutions to help clients successfully develop their medical products, pursue optimal regulatory pathways, build companies that are attractive to professional investors, and initiate access to global markets. Dr. Westelinck is a highly regarded pharmaceutical industry senior executive with significant experience in the development and regulatory approval of drugs in the US, EU and Asia. She was formerly Executive Director and Global Head of Regulatory Affairs, Oncology, for GlaxoSmithKline, Director of Regulatory Affairs at Hoffman-La Roche, and Visiting Scientist/Executive at the US Food & Drug Administration (FDA), Office of Drug Evaluation, Division of Oncology (CDER).

“Dr. Westelinck brings an extraordinary level of knowledge and expertise in oncology research, product development, and regulatory pathways in both the US and EU that will greatly benefit our clients in this field,” said Dr. Peck. “Oncology is presently a very active area for new drug development and we welcome Dr. Westelinck as a key contributor and leader in this practice area.”

In addition to global product development and regulatory strategy, Dr. Westelinck’s expertise includes innovative approaches in drug development (targeted therapies, immunotherapy, breakthrough therapies, novel-novel combinations, companion diagnostics, and innovative study designs) and emerging technologies (cell therapies, therapeutic RNA). She also provides strategic input for portfolio and licensing/deal-making decisions, and guidance for IND and NDA submissions, rare diseases, biomarkers, and accelerated approvals.

About NDA Partners

NDA Partners is a strategy consulting firm specializing in expert product development and regulatory advice to the medical products industry and associated service industries such as law firms, investment funds and government research agencies. The highly experienced Principals and Premier Experts of NDA Partners include two former FDA Center Directors; the former Chairman of the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK; an international team of approximately 40 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, expert consulting, high-impact project teams, and virtual product development teams.








NDA Partners Chairman Carl Peck, MD announced today that Agnes Westelinck, PharmD, a highly experienced pharmaceutical industry senior executive and former Executive Director and Global Head of Regulatory Affairs for Oncology, GlaxoSmithKline, has joined the firm as a Premier Expert consultant. NDA Partners Premier Experts are top tier consultants who design and implement critical solutions to help clients successfully develop new medical products, pursue optimal regulatory pathways, build companies that are attractive to professional investors, and initiate access to global markets. Former GlaxoSmithKline Senior Executive Agnes Westelinck Joins NDA Partners as a Premier Expert Consultant купить смартфон